18F-Fluciclovine PET/MRI for prostate cancer staging, androgen deprivation evaluation
Fluorine-18-labeled fluciclovine PET/MRI demonstrates utility in the initial staging of high-risk prostate cancer, as well as for evaluating the response to androgen deprivation therapyCredit: American...















